Matrix mineralization as a trigger for osteocyte maturation

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 6, 2008, Pages 561-567

  Irie, Kazuharu ^a   Ejiri, Sadakazu ^b   Sakakura, Yasunori ^a   Shibui, Toru ^a   Yajima, Toshihiko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Bisphosphonate; Bone matrix; Mineralization; Osteocyte; Sclerostin SOST

Indexed keywords

ETIDRONIC ACID; SCLEROSTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; MALE; MINERALIZATION; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MATRIX; CALCIFICATION, PHYSIOLOGIC; ETIDRONIC ACID; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE; MICROSCOPY, ELECTRON; OSTEOCYTES; RATS; RATS, WISTAR;

RATTUS;

EID: 43949094516     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.950527     Document Type: Article

References (25)

1. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, et al. (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537-543
2. Bellido T (2006) Summary: Osteocyte control of bone formation via Sost/sclerostin. J Musculoskelet Neuronal Interact 6:360-363
3. Bonewald L (2006a) Osteocytes as multifunctional cells. J Musculoskelet Neuronal Interact 6:331-333
4. Bonewald LF (2006b) Mechanosensation and transduction in osteocytes. Bonekey Osteovision 3:7-15
5. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, et al. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589
6. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, et al. (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310-1315
7. Fleisch H (1981) Diphosphonates: history and mechanisms of action. Metab Bone Dis Relat Res 3:279-287
8. Fleisch H, Russell RG (1972) A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth. J Dent Res 51:324-332
9. Hirao M, Hashimoto J, Yamasaki N, Ando W, Tsuboi H, Myoui A, Yoshikawa H (2007) Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J Bone Miner Metab 25:266-276
10. Irie K, Ozawa H (1990) Relationships between tooth eruption, occlusion and alveolar bone resorption: cytological and cytochemical studies of bone resorption on rat incisor alveolar bone facing the enamel. Arch Histol Cytol 53:497-509
11. Irie K, Ozawa H, Yajima T (2000) The histochemical and cytochemical changes from formative to resorptive osteocytes. Acta Histochem Cytochem 33:385-391
12. Jande SS, Belanger LF (1973) The life cycle of the osteocyte. Clin Orthop Relat Res 94:281-305
13. Khatiwala CB, Peyton SR, Putnam AJ (2006) Intrinsic mechanical properties of the extracellular matrix affect the behavior of preosteoblastic MC3T3-E1 cells. Am J Physiol Cell Physiol 290: C1640-1650
14. Mikuni-Takagaki Y, Suzuki Y, Kawase T, Saito S (1996) Distinct responses of different populations of bone cells to mechanical stress. Endocrinology 137:2028-2035
15. Morris DC, Anderson HC, Yoshikawa H, Nakahara H, Takaoka K, Ono K (1990) Matrix vesicle calcification of ectopically induced osteoid tissue in 1-hydroxethylidene-1,1-bisphosphonate (HEBP)-treated mice. Bone 11:281-286
16. Nakahara H, Yoshikawa H, Takaoka K, Ono K (1986) Effect of ethane-1-hydroxy-1,1-diphosphonate on ectopic bone formation induced by murine osteosarcoma-derived bone-inducing substance. Bone 7:229-233
17. Nijweide PJ, Burger EH, Klein-Nulend J (2002) The osteocyte. In Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. London, Academic Press, 93-107
18. Peyton SR, Ghajar CM, Khatiwala CB, Putnam AJ (2007) The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function. Cell Biochem Biophys 47:300-320
19. Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Lowik CW, Reeve J (2005) Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEBJ 19:1842-1844
20. Schenk R, Merz WA, Muhlbauer R, Russell RG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196-214
21. van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, et al. (2004) Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199:805-814
22. van Bezooijen RL, Svensson JP, Eefting D, Visser A, van der Horst G, Karperien M, Quax PH, et al. (2007) Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Miner Res 22:19-28
23. van Bezooijen RL, ten Dijke P, Papapoulos SE, Lowik CW (2005) SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16:319-327
24. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, et al. (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22:6267-6276
25. Zhang K, Barragan-Adjemian C, Ye L, Kotha S, Dallas M, Lu Y, Zhao S, et al. (2006) E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol 26:4539-4552